Expression of concern
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Paper Information
Record ID:
35165
Author(s):
Journal:
Publication Date:
February 02, 2017
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Pharmacology and Therapeutics, University of Porto
- MedInUP, Centre for Drug Discovery and Innovative Medicines
- Centro Hospitalar Sao Joao, Porto, Portugal
- IBD Unit, DIMEC, University of Bologna, Bologna, Italy
- Department of Gastroenterology and Hepatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
- Gastrointestinal Unit ASST Fatebenefratelli Sacco—University of Milan—Milan, Italy
- IBD Unit Complesso Integrato Columbus, Gastroenterological and Endocrino-Metabolical Science Department, Fondazione Policlinico Universitario Gemelli Universita Cattolica del Sacro Cuore, Rome, Italy
- Department of Gastroenterology, IBD Unit, University Hospital Santiago De Compostela (CHUS), A Coruna, Spain
- Department of Gastroenterology, North Zealand University Hospital, Frederikssund, Denmark
- First Department of Medicine, Semmelweis University, Budapest, Hungary IBD Unit, St Mark’s Hospital, Middlesex, UK
- Department of Gastroenterology, University Hospital of Ghent, Ghent, Belgium
- Institute of Pathology, Medical University of Graz, Graz, Austria
- Department of Gastroenterology, Pennine Acute Hospitals NHS Trust
- Institute of Inflammation and Repair, University of Manchester, Manchester, UK
- Unit of General Surgery, Second University of Naples, Napoli, Italy
- Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Department of Oncological Gastroenterology Warsaw
- Medical Centre for Postgraduate Education, Department of Gastroenterology, Hepatology and Clinical Oncology, Warsaw, Poland
- Department of Medicine, University of Cambridge, Cambridge, UK
- Imperial College London
- Chelsea and Westminster Hospital, London, UK
- Department of Pathobiology NC22, Lerner Research Institute
- Department of Gastroenterology, Hepatology and Nutrition/A3, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1718)
1718
Total Citations766
Post-Retraction(44.6%)
945
Pre-Retraction4
Same DayPost-Retraction Citation Analysis
16
Within 30 days
275
Within 1 year
255
After 2+ years
1274
Days since retraction (latest)
Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases
Joseph Carter Powers, Benjamin L. Cohen, Florian Rieder et al. (10 authors)
Inflammatory Bowel Diseases
Published: Apr 2023
1 citation
1 citation
446 days after retraction
Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future
E C S D Oliveira, Ana Elisa Valencise Quaglio, Daniéla Oliveira Magro et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2023
30 citations
30 citations
444 days after retraction
Maladies inflammatoires chroniques intestinales : scores et optimisation des comptes rendus anatomopathologiques
Camille Boulagnon‐Rombi, Aude Marchal, Marion Lirsac et al. (4 authors)
Annales de Pathologie
Open Access
Published: Apr 2023
1 citation
1 citation
443 days after retraction
Time trend in surgical indications and outcomes in ulcerative colitis—A two decades in-depth retrospective analysis
Guillaume Le Cosquer, Lena Capirchio, Pauline Rivière et al. (12 authors)
Digestive and Liver Disease
Open Access
Published: Apr 2023
2 citations
2 citations
436 days after retraction
Identification of Critical Modules and Biomarkers of Ulcerative Colitis by Using WGCNA
Yifan Yuan, Na Li, Mingyue Fu et al. (4 authors)
Journal of Inflammation Research
Open Access
Published: Apr 2023
12 citations
12 citations
432 days after retraction
Efficacy of Qifu Lizhong enema prescription on intestinal mucosal tight junction function modulation of ulcerative colitis rat model.
Jing Cheng, Lü Shangbin, Zhang Yi et al. (7 authors)
PubMed
Published: Apr 2023
4 citations
4 citations
432 days after retraction
Photodynamic Therapy of Rectum Stump in Patients with Ulcerative Proctitis
D. Yu. Semenov, V. K. Shubin, С. Г. Терещенко et al. (13 authors)
Nauka molodykh (Eruditio Juvenium)
Open Access
Published: Mar 2023
431 days after retraction
Vedolizumab for the Treatment of Chronic Pouchitis
Simon Travis, Mark S. Silverberg, Silvio Danese et al. (14 authors)
New England Journal of Medicine
Open Access
Published: Mar 2023
78 citations
78 citations
429 days after retraction
SURGICAL MANAGEMENT OF ADULT CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN’S DISEASE AND COLITIS (GEDIIB)
Gilmara Pandolfo Zabot, Ornella Sari Cassol, Abel Botelho Quaresma et al. (18 authors)
Arquivos de Gastroenterologia
Open Access
Published: Mar 2023
5 citations
5 citations
424 days after retraction
Risk factors for postoperative recurrence of ulcerative colitis-associated colorectal cancer
Yuki Horio, Motoi Uchino, Masataka Igeta et al. (11 authors)
Research Square (Research Square)
Open Access
Published: Mar 2023
424 days after retraction
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN’S DISEASE AND COLITIS (GEDIIB)
Júlio Pinheiro Baima, Marcello Imbrizi, Adriana Ribas Andrade et al. (34 authors)
Arquivos de Gastroenterologia
Open Access
Published: Mar 2023
11 citations
11 citations
424 days after retraction
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN’S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN’S DISEASE AND COLITIS (GEDIIB)
Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo et al. (33 authors)
Arquivos de Gastroenterologia
Open Access
Published: Mar 2023
11 citations
11 citations
424 days after retraction
Risks Factors Associated with the Development of Crohn’s Disease After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Systematic Review and Meta-Analysis
Michael G Fadel, Georgios Geropoulos, Oliver Warren et al. (7 authors)
Journal of Crohn s and Colitis
Open Access
Published: Mar 2023
10 citations
10 citations
422 days after retraction
Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis
Gregor Novak, Nejc Sever, Jurij Hanžel et al. (8 authors)
European Journal of Gastroenterology & Hepatology
Published: Mar 2023
1 citation
1 citation
418 days after retraction
Accuracy of Transperineal Ultrasonography for Assessing Rectal Lesions in Paediatric Ulcerative Colitis: A Prospective Study
Keisuke Jimbo, Kenji Hosoi, Mitsuyoshi Suzuki et al. (11 authors)
Journal of Crohn s and Colitis
Published: Mar 2023
6 citations
6 citations
415 days after retraction
Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids
Mette Klitgaard, Maja Nørgaard Kristensen, Ramakrishnan Venkatasubramanian et al. (8 authors)
Drug Delivery and Translational Research
Published: Mar 2023
4 citations
4 citations
413 days after retraction
Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation
Sofija Lugonja, Ivana Pantić, Tamara Alempijević et al. (10 authors)
Medicina
Open Access
Published: Mar 2023
4 citations
4 citations
411 days after retraction
Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life
Maojuan Li, Tao Yan, Yang Sun et al. (12 authors)
Frontiers in Medicine
Open Access
Published: Mar 2023
2 citations
2 citations
409 days after retraction
What Is the Risk? Epidemiology and Evidence for Surveillance Regimens
Bianca N. Islam, Vu Q. Nguyen
Clinics in Colon and Rectal Surgery
Published: Mar 2023
408 days after retraction
Evolution after withdrawal of infliximab in patients with inflammatory bowel disease: RET-INF-EII study
FJ Mata Perdigón, Á Bernal Torres, A. Viejo Almanzor
Revista Andaluza de Patología Digestiva
Open Access
Published: Mar 2023
408 days after retraction
Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye-chromoendoscopy
Beatriz Sicilia, Yago González‐Lama, Benito Velayos et al. (14 authors)
Endoscopy International Open
Open Access
Published: Mar 2023
1 citation
1 citation
406 days after retraction
Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register
E. А. Belousova, Yu. A. Shelygin, С. И. Ачкасов et al. (23 authors)
Koloproktologia
Open Access
Published: Mar 2023
14 citations
14 citations
406 days after retraction
Negative outcomes in stomas and periestoma skin of individuals with inflammatory bowel diseases – Retrospective Cohort
Thaís Martins Gomes de Oliveira, Alexandra Isabel De Amorim Lino, Cristine Alves Costa de Jesus
Concilium
Open Access
Published: Mar 2023
2 citations
2 citations
402 days after retraction
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019
Rui Wang, Zhaoqi Li, Shaojun Liu et al. (4 authors)
BMJ Open
Open Access
Published: Mar 2023
336 citations
336 citations
401 days after retraction
Mise à jour sur le traitement médicamenteux de la colite ulcéreuse
Jasmina El Hadad, Philipp Schreiner, Thomas Greuter
Schweizer Gastroenterologie
Open Access
Published: Mar 2023
401 days after retraction
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
Giammarco Mocci, Antonio Tursi, Giovanni Maconi et al. (64 authors)
Expert Opinion on Biological Therapy
Published: Feb 2023
5 citations
5 citations
399 days after retraction
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone
Tamás Resál, Katalin Mangó, P Bacsúr et al. (15 authors)
Expert Opinion on Drug Safety
Published: Feb 2023
2 citations
2 citations
394 days after retraction
Risk prediction model based on blood biomarkers for predicting moderate to severe endoscopic activity in patients with ulcerative colitis
Xiaojuan Li, Zihui Tang, Yanbing Liu et al. (5 authors)
Frontiers in Medicine
Open Access
Published: Feb 2023
6 citations
6 citations
393 days after retraction
Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights
Sumaiah J. Alarfaj, Sally Abdallah Mostafa, Walaa A. Negm et al. (7 authors)
Pharmaceuticals
Open Access
Published: Feb 2023
7 citations
7 citations
392 days after retraction
The urotensin‐II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis
Antonietta Gerarda Gravina, Marcello Dallio, Mario Romeo et al. (13 authors)
European Journal of Clinical Investigation
Published: Feb 2023
6 citations
6 citations
390 days after retraction
Hocus Pocus: the Role of Hand-held Ultrasonography in Predicting Disease Extension and Endoscopic Activity in Ulcerative Colitis
Antonio Rispo, Giulio Calabrese, Anna Testa et al. (10 authors)
Journal of Crohn s and Colitis
Open Access
Published: Feb 2023
14 citations
14 citations
388 days after retraction
Optimización del tratamiento de la colitis ulcerosa leve a moderada: Consenso Delphi CU-Forum
Miquel Sans Cuffi, Federico Argüelles‐Arias, Ana Echarri et al. (6 authors)
Gastroenterología y Hepatología
Published: Feb 2023
387 days after retraction
The Role of Artificial Intelligence in Monitoring Inflammatory Bowel Disease—The Future Is Now
Claudia Diaconu, Monica State, Mihaela Bîrligea et al. (8 authors)
Diagnostics
Open Access
Published: Feb 2023
13 citations
13 citations
387 days after retraction
Neutrophil Membrane-Coated Mesoporous Silica Nanoparticles Loaded with Hydrocortisone Alleviate DSS-Induced Colitis in Mice
Guozhen Wang, Yongshuai Qi, Jia Xu et al. (11 authors)
ACS Applied Nano Materials
Published: Feb 2023
2 citations
2 citations
385 days after retraction
Comparison of Restorative Proctocolectomy with and Without Defunctioning Loop Ileostomy in Patients with Ulcerative Colitis: A Systematic Review and Meta-analysis
Mark Donnelly, Odhrán K. Ryan, Éanna J. Ryan et al. (10 authors)
Journal of Crohn s and Colitis
Published: Feb 2023
4 citations
4 citations
385 days after retraction
Impact of the body mass index on the retention of the anorectal mucosa after double-stapled ileal pouch-anal anastomosis for ulcerative colitis
Hideaki Kimura, Kenichiro Toritani, Reiko Kunisaki et al. (7 authors)
BMC Gastroenterology
Open Access
Published: Feb 2023
2 citations
2 citations
380 days after retraction
Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
Clara Amiama Roig, Cristina Suárez Ferrer, J L Rueda García et al. (9 authors)
Gastroenterología y Hepatología (English Edition)
Published: Feb 2023
1 citation
1 citation
373 days after retraction
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease
Giorgia Colombo, Gian Paolo Caviglia, Alberto Ravera et al. (9 authors)
Frontiers in Medicine
Open Access
Published: Feb 2023
7 citations
7 citations
373 days after retraction
Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
Constanza Bay, Paulina Núñez, Rodrigo Quera et al. (4 authors)
Gastroenterología y Hepatología (English Edition)
Published: Feb 2023
373 days after retraction
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
Renato Sablich, Maria Teresa Urbano, Marco Scarpa et al. (6 authors)
Scientific Reports
Open Access
Published: Feb 2023
14 citations
14 citations
373 days after retraction
Incremental Detection Rate of Dysplasia and Sessile Serrated Polyps/Adenomas Using Narrow-Band Imaging and Dye Spray Chromoendoscopy in Addition to High-Definition Endoscopy in Patients with Long-Standing Extensive Ulcerative Colitis: Segmental Tandem Endoscopic Study
Ji Eun Kim, Chang Wan Choi, Sung Noh Hong et al. (7 authors)
Diagnostics
Open Access
Published: Jan 2023
1 citation
1 citation
372 days after retraction
Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management
Viviana Laredo, Sandra G. García, Samuel J. Martínez‐Domínguez et al. (6 authors)
Cancers
Open Access
Published: Jan 2023
47 citations
47 citations
372 days after retraction
The genetics of non-monogenic IBD
Deborah Sarah Jans, Isabelle Cleynen
Human Genetics
Published: Jan 2023
22 citations
22 citations
372 days after retraction
Guía GADECCU 2022 para el tratamiento de la colitis ulcerosa. Adaptación y actualización de la Guía GETECCU 2020
Claudia Fuxman, Beatriz Sicilia, María Eugenia Linares et al. (22 authors)
Gastroenterología y Hepatología
Open Access
Published: Jan 2023
3 citations
3 citations
372 days after retraction
Inflammatory Bowel Disease and Colorectal Cancer
Tamara Glyn, Amy L. Lightner
Digestive Disease Interventions
Published: Jan 2023
360 days after retraction
In situ polyphenol-adhesive hydrogel enhanced the noncarcinogenic repairing of KGF on the gut epithelial barrier on TNBS-induced colitis rats
Gaolong Lin, Jiaojiao Yang, Jiayi Liu et al. (10 authors)
International Journal of Biological Macromolecules
Published: Jan 2023
7 citations
7 citations
358 days after retraction
The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study
Edyta Szymańska, Sylwia Szymańska, Agnieszka Karkucińska‐Więckowska et al. (6 authors)
Gastrointestinal Disorders
Open Access
Published: Jan 2023
1 citation
1 citation
353 days after retraction
Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence
Zheng-lan Duan, Yuji Wang, Zhihua Lü et al. (17 authors)
Phytomedicine
Open Access
Published: Jan 2023
82 citations
82 citations
353 days after retraction
Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
Livia Lontai, Zsuzsanna Kürti, Lóránt Gönczi et al. (7 authors)
The Turkish Journal of Gastroenterology
Open Access
Published: Jan 2023
4 citations
4 citations
346 days after retraction
Managing ulcerative colitis after surgery
Cristina Suárez, R Ferreiro-Iglesias, Iria Baston Rey et al. (4 authors)
Frontiers in Medicine
Open Access
Published: Jan 2023
8 citations
8 citations
345 days after retraction
Quick Stats
Total Citations:
1718
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025